Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.
2.

Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.

Dorvault CC, Weilbaecher KN, Yee H, Fisher DE, Chiriboga LA, Xu Y, Chhieng DC.

Cancer. 2001 Oct 25;93(5):337-43.

PMID:
11668469
3.

Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.

Petitt M, Allison A, Shimoni T, Uchida T, Raimer S, Kelly B.

J Am Acad Dermatol. 2009 Nov;61(5):819-28. doi: 10.1016/j.jaad.2009.04.026.

PMID:
19836642
4.

Sentinel node identification by scintigraphic methods in cutaneous melanoma.

Dias Moreira R, Altino de Almeida S, Maliska Guimarães CM, Resende JF, Gutfilen B, Barbosa da Fonseca LM.

J Exp Clin Cancer Res. 2005 Jun;24(2):181-5.

PMID:
16110749
5.

Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.

Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE.

Am J Dermatopathol. 2001 Jun;23(3):185-9.

PMID:
11391097
6.

Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors.

Chang KL, Folpe AL.

Adv Anat Pathol. 2001 Sep;8(5):273-5. Review.

PMID:
11556535
7.

Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.

Shidham VB, Qi DY, Acker S, Kampalath B, Chang CC, George V, Komorowski R.

Am J Surg Pathol. 2001 Aug;25(8):1039-46.

PMID:
11474288
8.

Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement.

Claessens N, Piérard GE, Piérard-Franchimont C, Arrese JE, Quatresooz P.

Melanoma Res. 2005 Apr;15(2):107-10.

PMID:
15846143
9.

Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.

Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R.

Melanoma Res. 2007 Dec;17(6):393-9.

PMID:
17992123
10.

Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.

Miettinen M, Fernandez M, Franssila K, Gatalica Z, Lasota J, Sarlomo-Rikala M.

Am J Surg Pathol. 2001 Feb;25(2):205-11.

PMID:
11176069
11.

Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors.

King R, Googe PB, Weilbaecher KN, Mihm MC Jr, Fisher DE.

Am J Surg Pathol. 2001 Jan;25(1):51-7.

PMID:
11145251
12.

Sentinel lymph node: detection of micrometastases of melanoma in a molecular study.

Denninghoff VC, Kahn AG, Falco J, Curutchet HP, Elsner B.

Mol Diagn. 2004;8(4):253-8.

PMID:
15887981
13.

Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.

Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.

Arch Dermatol. 2009 Oct;145(10):1105-13. doi: 10.1001/archdermatol.2009.209.

PMID:
19841396
14.

KBA.62: a useful marker for primary and metastatic melanomas.

Pagès C, Rochaix P, al Saati T, Valmary-Degano S, Boulinguez S, Launay F, Carle P, Lauwers F, Payoux P, Le Guellec S, Brousset P, Lamant L.

Hum Pathol. 2008 Aug;39(8):1136-42. doi: 10.1016/j.humpath.2007.12.006. Epub 2008 May 20.

PMID:
18495211
15.

Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision.

Abrahamsen HN, Hamilton-Dutoit SJ, Larsen J, Steiniche T.

Cancer. 2004 Apr 15;100(8):1683-91.

16.

Identification of nodal metastases in melanoma using sox-10.

Jennings C, Kim J.

Am J Dermatopathol. 2011 Jul;33(5):474-82. doi: 10.1097/DAD.0b013e3182042893.

PMID:
21552103
17.

Idiosyncrasies of scalp melanoma.

Rigual NR, Cheney RT, Iwenofu OH, Li Q, Loree TR, Popat SR, Merzianu M.

Laryngoscope. 2007 Aug;117(8):1354-8.

PMID:
17592396
18.

Microphthalmia transcription factor: a specific marker for malignant melanoma.

Vachtenheim J, Borovanský J.

Prague Med Rep. 2004;105(3):318-24. Review.

PMID:
15782558
19.

Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes.

Mentrikoski MJ, Ma L, Pryor JG, McMahon LA, Yang Q, Spaulding BO, Scott GA, Wang HL, Xu H.

Mod Pathol. 2009 Dec;22(12):1582-7. doi: 10.1038/modpathol.2009.128. Epub 2009 Sep 4.

20.

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.

Koh SS, Wei JP, Li X, Huang RR, Doan NB, Scolyer RA, Cochran AJ, Binder SW.

Mod Pathol. 2012 Jun;25(6):828-37. doi: 10.1038/modpathol.2012.32. Epub 2012 Mar 9.

Supplemental Content

Support Center